Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease

被引：22

作者：

Assouan, Deborah ^{[1
]}

Lebon, Delphine ^{[1
]}

Charbonnier, Amandine ^{[1
]}

Royer, Bruno ^{[1
]}

Marolleau, Jean-Pierre ^{[1
]}

Gruson, Berengere ^{[1
]}

机构：

[1] Ctr Hosp Univ Amiens, Hematol, Amiens, France

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 05期

关键词：

graft-versus-host disease; hematopoietic stem cell transplantation; ruxolitinib; malignant haematology; corticosteroids; TRANSPLANTATION;

D O I：

10.1111/bjh.14679

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：687 / 689

页数：3

共 9 条

[1] Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect [J].

Choi, Jaebok ;

Cooper, Matthew L. ;

Alahmari, Bader ;

Ritchey, Julie ;

Collins, Lynne ;

Holt, Matthew ;

DiPersio, John F. .

PLOS ONE, 2014, 9 (10)

[2] How I treat refractory acute GVHD [J].

Deeg, H. Joachim .

BLOOD, 2007, 109 (10) :4119-4126

[3] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report [J].

Filipovich, AH ;

Weisdorf, D ;

Pavletic, S ;

Socie, G ;

Wingard, JR ;

Lee, SJ ;

Martin, P ;

Chien, J ;

Przepiorka, D ;

Couriel, D ;

Cowen, EW ;

Dinndorf, P ;

Farrell, A ;

Hartzman, R ;

Henslee-Downey, J ;

Jacobsohn, D ;

McDonald, G ;

Mittleman, B ;

Rizzo, JD ;

Robinson, M ;

Schubert, M ;

Schultz, K ;

Shulman, H ;

Turner, M ;

Vogelsang, G ;

Flowers, MED .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) :945-956

[4] Treatment and management of graft-versus-host disease: improving response and survival [J].

Garnett, Catherine ;

Apperley, Jane F. ;

Pavlu, Jiri .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (06) :366-378

[5] JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis [J].

Harrison, Claire ;

Kiladjian, Jean-Jacques ;

Al-Ali, Haifa Kathrin ;

Gisslinger, Heinz ;

Waltzman, Roger ;

Stalbovskaya, Viktoriya ;

McQuitty, Mari ;

Hunter, Deborah S. ;

Levy, Richard ;

Knoops, Laurent ;

Cervantes, Francisco ;

Vannucchi, Alessandro M. ;

Barbui, Tiziano ;

Barosi, Giovanni .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :787-798

[6] First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation [J].

Martin, Paul J. ;

Rizzo, J. Douglas ;

Wingard, John R. ;

Ballen, Karen ;

Curtin, Peter T. ;

Cutler, Corey ;

Litzow, Mark R. ;

Nieto, Yago ;

Savani, Bipin N. ;

Schriber, Jeffrey R. ;

Shaughnessy, Paul J. ;

Wall, Donna A. ;

Carpenter, Paul A. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) :1150-1163

[7] IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade [J].

Rowlings, PA ;

Przepiorka, D ;

Klein, JP ;

Gale, RP ;

Passweg, JR ;

HensleeDowney, PJ ;

Cahn, JY ;

Calderwood, S ;

Gratwohl, A ;

Socie, G ;

Abecasis, MM ;

Sobocinski, KA ;

Zhang, MJ ;

Horowitz, MM .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) :855-864

[8] Prognostic value of response after upfront therapy for acute GVHD [J].

Saliba, R. M. ;

Couriel, D. R. ;

Giralt, S. ;

Rondon, G. ;

Okoroji, G-J ;

Rashid, A. ;

Champlin, R. E. ;

Alousi, A. M. .

BONE MARROW TRANSPLANTATION, 2012, 47 (01) :125-131

[9] Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey [J].

Zeiser, R. ;

Burchert, A. ;

Lengerke, C. ;

Verbeek, M. ;

Maas-Bauer, K. ;

Metzelder, S. K. ;

Spoerl, S. ;

Ditschkowski, M. ;

Ecsedi, M. ;

Sockel, K. ;

Ayuk, F. ;

Ajib, S. ;

de Fontbrune, F. S. ;

Na, I-K ;

Penter, L. ;

Holtick, U. ;

Wolf, D. ;

Schuler, E. ;

Meyer, E. ;

Apostolova, P. ;

Bertz, H. ;

Marks, R. ;

Luebbert, M. ;

Waesch, R. ;

Scheid, C. ;

Stoelzel, F. ;

Ordemann, R. ;

Bug, G. ;

Kobbe, G. ;

Negrin, R. ;

Brune, M. ;

Spyridonidis, A. ;

Schmitt-Graeff, A. ;

van der Velden, W. ;

Huls, G. ;

Mielke, S. ;

Grigoleit, G. U. ;

Kuball, J. ;

Flynn, R. ;

Ihorst, G. ;

Du, J. ;

Blazar, B. R. ;

Arnold, R. ;

Kroeger, N. ;

Passweg, J. ;

Halter, J. ;

Socie, G. ;

Beelen, D. ;

Peschel, C. ;

Neubauer, A. .

LEUKEMIA, 2015, 29 (10) :2062-2068

← 1 →